Quantum Biopharma (QNTM) Net Cash Flow (2019 - 2026)

Quantum Biopharma has disclosed Net Cash Flow across 7 years of filings, most recently posting $2.4 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at $2.4 million, up 198.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 63.84% YoY), and the FY2025 annual result was -$4.1 million, down 226.3% from the prior year.
• Net Cash Flow came in at $2.4 million for Q1 2026 at Quantum Biopharma, up from $1.5 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $9.7 million in Q2 2022 to a low of -$42.5 million in Q4 2022.
• The 4-year median for Net Cash Flow is $1.5 million (2025), against an average of -$1.0 million.
• Across the five-year window, Net Cash Flow slumped 153.26% in 2025 and soared 198.34% in 2026, its largest moves.
• Quantum Biopharma's Net Cash Flow stood at -$42.5 million in 2022, then surged by 106.76% to $2.9 million in 2024, then sank by 49.25% to $1.5 million in 2025, then jumped by 66.95% to $2.4 million in 2026.
• The last three Net Cash Flow figures came in at $2.4 million (Q1 2026), $1.5 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.